Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 25	Sep ' 24	Sep ' 23	Sep ' 22	Mar ' 22

Sales

1,020.77

1,195.91

1,015.61

904.43

895.22

Operating profit

129.45

128.79

98.83

-66.56

21.48

Interest

59.86

98.53

76.70

60.68

38.15

Gross profit

85.44

61.90

56.12

-99.30

75.66

EPS (Rs)

4.92

1.93

1.03

-7.78

20.37

Other income

15.85

31.64

33.99

27.94

92.33

Stock adjustment

11.82

17.85

7.12

0.30

42.59

Raw material

466.64

568.05

504.04

578.98

475.71

Power and fuel

-

-

-

-

-

Employee expenses

190.53

199.07

162.95

137.54

121.01

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

222.33

282.15

242.67

254.17

234.43

Provisions made

-

-

-

-

-

Depreciation

43.65

43.89

42.80

48.65

50.64

Taxation

-3.60

0.29

4.04

-77.70

-157.88

Net profit / loss

45.39

17.71

9.29

-70.25

182.90

Extra ordinary item

-

-0.01

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

92.16

91.96

90.30

90.29

89.79

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

12.68

10.77

9.73

-7.36

2.40

GPM (%)

8.24

5.04

5.35

-10.65

7.66

NPM (%)

4.38

1.44

0.88

-7.53

18.52